Liver Transplanted Patients Completed Phase 4 Trials for Losartan (DB00678)

Also known as: Liver Transplant Recipients / Liver Transplant Recipient

IndicationStatusPhase
DBCOND0066753 (Liver Transplanted Patients)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00275639The Effects of Angiotensin II Receptor Blockade on Kidney Function and Scarring After Liver TransplantTreatment